The new Assisted Reproductive Technology (ART) regulations in India have brought significant changes in the landscape of reproductive healthcare. Some of the major changes are:

• Facilitation of surrogacy only for Indian married infertile couples or a woman with a medical condition that prevents her from carrying a pregnancy to term.
• Prohibition of commercial surrogacy, where the surrogate mother can only receive reimbursement for medical expenses and insurance coverage.
• Made compulsory the setting up of ART clinics only with the required facilities and infrastructure.
• Several regulations have been imposed on gamete donation, including a maximum age limit of 35 years for egg donors and 14 years for semen donors.
• Preconception and genetic counseling for the couple before initiating ART treatment.

These regulations have led to an increase in the cost of treatment as clinics now have to invest more in infrastructure and mandatory testing to ensure the highest quality of treatment. However, there is hope for improved conception opportunities as these regulations seek to ensure the safety and ethical standards of ART procedures for couples seeking to use them.